Get the Stockscreener App
103.46
3.21%
3.21
Ishares U S Pharmaceuticals Etf stock is traded at $103.46, with a volume of 77,584.
It is up +3.21% in the last 24 hours and up +11.63% over the past month.
See More
Previous Close:
$100.25
Open:
$102.65
24h Volume:
77,584
Relative Volume:
0.69
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+4.50%
1M Performance:
+11.63%
6M Performance:
+20.10%
1Y Performance:
+57.03%
1-Day Range:
$102.65
$103.51
1-Week Range:
$97.84
$103.51
52-Week Range:
$64.94
$103.51
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Name
Ishares U S Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare IHE vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IHE
Ishares U S Pharmaceuticals Etf
|
103.48 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
369.27 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
746.70 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
750.05 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
298.88 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
707.32 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf Stock (IHE) Latest News
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Yahoo Finance
iShares U.S. Pharmaceuticals ETF (IHE) Stock Price Quote Today & Current Price Chart - Capital.com
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors? - AOL.com
IShares TrustiShares U.S. Pharmaceuticals ETF announces Quarterly dividend, payable on June 18, 2026 - marketscreener.com
Ditch or double down on this pharma ETF as Trump adjusts drug prices? - MSN
Even if Eli Lilly stock continues to shine, stay away from this pharmaceutical ETF - MSN
Axsome Therapeutics Inc (AXSM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Prestige Consumer Healthcare Inc (PBH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Crinetics Pharmaceuticals Inc (CRNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Evolus Inc (EOLS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Royalty Pharma PLC (RPRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amylyx Pharmaceuticals Inc (AMLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ligand Pharmaceuticals Inc (LGND) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Elanco Animal Health Inc (ELAN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LENZ Therapeutics Inc (LENZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Johnson & Johnson (JNJ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Jazz Pharmaceuticals PLC (JAZZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Avadel Pharmaceuticals PLC (AVDL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Enliven Therapeutics Inc (ELVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arvinas Inc (ARVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amneal Pharmaceuticals Inc (AMRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Zoetis Inc (ZTS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Phathom Pharmaceuticals Inc (PHAT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Viatris Inc (VTRS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tarsus Pharmaceuticals Inc (TARS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nuvation Bio Inc (NUVB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Eli Lilly and Co (LLY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Supernus Pharmaceuticals Inc (SUPN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pfizer Inc (PFE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Trump Administration Prepares Up To 100% Pharma Tariffs On Drugs From Companies That Have Not Struck A Deal Yet: Report - Stocktwits
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns - AOL.com
Healthcare ETFs: From Broad Exposure to Big Breakthroughs - ETF Database
The iShares U.S. Pharmaceutical ETF Has Achieved a Return of Over 42% in the Past Year - NAI500
iShares vs Simplify Health Care ETFs: A Comparison of Two Healthcare Funds - IndexBox
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns - The Motley Fool
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - TradingView
IXUS vs. IEFA: Which International ETF Is Better for Most Investors? - The Motley Fool
Middle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike - The Globe and Mail
Pharma stocks are showing strength. Charts predict this name could break out next - CNBC
iShares MSCI World ETF Faces a Crucible of Rate Fears, a Dividend Date, and a Landmark Space IPO - AD HOC NEWS
Sector Update: Healthcare - Moomoo
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
Flow Focus | Marvell Ripped, Broadcom Cracked — AI Money Is Getting Pickier - Moomoo
MSCI World ETF Caught Between a Mega-IPO and a Narrowing Market - AD HOC NEWS
The Technical Signals Behind (IHE) That Institutions Follow - Stock Traders Daily
iShares MSCI World ETF Faces a Congested June Calendar: Dividend, Fed Decision, and Tariff Fallout - AD HOC NEWS
The $12 Billion Index Mechanic: Why the MSCI World ETF Cannot Dodge SpaceX’s Mega-IPO - AD HOC NEWS
MACD Signal Flashes Bullish for MSCI World ETF, but Pharma Tariffs and SpaceX Add to the Risk Stack - AD HOC NEWS
ETF Diversification and IHE Analysis - asatunews.co.id
The iShares MSCI World ETF: A Record High Surrounded by a Thicket of Risks - AD HOC NEWS
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Yahoo Finance
Ishares U S Pharmaceuticals Etf Stock (IHE) Financials Data
There is no financial data for Ishares U S Pharmaceuticals Etf (IHE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.19%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):